groups of animals, plasma levels of insulin and glucagon and hepatic (graft) activities of thymidine kinase and ornithine decarboxylase were followed serially. The only difference between the two groups of animals for these measures was that the ornithine decarboxylase activity rose to a greater degree in the liver that underwent graft enlargement. These data suggest that recipient size determines, at least in part, liver graft size once it is transplanted. These data also suggest that of the parameters followed, only ornithine decarboxylase activity parallels the finding of growth of the transplanted liver.
Occasionally, in clinical liver transplantation, a liver from a small donor is transplanted into a much larger recipient because of urgent need and inability of the transplanting surgeons to identify a more appropriate donor. In such cases, we have noted that the intact transplanted organ rapidly increases in size to achieve a size comparable to that of a normal liver within a normal individual of the size and age as the recipient over a period of 2 weeks (1). To investigate the mechanisms responsible for this phenomenon, the following studies were performed.
MATERIALS AND ~ETHODS Animals. Orthotopic liver transplantation (OLTx) was performed in two groups of young adult mongrel dogs using a modification of the procedure originally described by Starzl et al, (2) . The first group of experimental animals consisted of seven large dogs weighing 23.7 ± 0.8 kg (S.E.). All dogs in this group underwent hepatectomy and were given allograft organs obtained from smaller dogs (mixed breed young adults) that weighed 13.2 ± 0.4 kg. A second group of animals acting as controls underwent hepatectomy and was transplanted with organs obtained from young adult animals of the same size (recipient animal's weight = 18.7 ± 4.6 kg; donor animal's weight = 19.5 ± 4.5 kg). Prior to OLTx, all dogs had a computed tomography (CT) scan of their liver to determine their hepatic volume using a recently described technique (3).
Experimental Design. At the time of hepatectomy and immediately upon removal from the animal, the weight of the livers of all donors and recipient animals was determined by weighing the organs to the nearest gram. Following OLTx, serial liver volume determinations were obtained by repeat CT scanning procedures. In addition, blood samples were obtained at predetermined regular intervals for measurement of total bilirubin, ALT (or SGPT), glucagon and insulin levels at 0, 2, 4,6,8,10,12,14 and 30 days. At termination of the experiment, the weight of the allograft liver to the nearest gram was determined immediately upon sacrifice, for all of the animals, by reweighing the removed allograft organ. All animals were treated with cyclosporine A at a dose of 20 mg per kg per day to prevent allograft rejection.
The entire protocol was repeated in an additional group of separate animals for the determination of the hepatic content of both ornithine decarboxylase and thymidine kinase and an examination of the histopathologic consequences of liver transplantation.
Liver CT Scanning. CT scans of the liver for volume determinations were obtained on a General Electric model 9800 CT scanner. Serial transverse scans at 1 cm intervals from the dome of the liver through the most inferior portion of the organ were obtained with the dog's respiration suspended in full expiration. Using a track ball device, the perimeter of each slice of the liver was outlined, and the enclosed area was calculated electronically. Total hepatic volume was obtained by summing the volumes of individual slices. Intraobserver error for measuring a single slice or for measuring the total liver volume was ::::;5%. llfeasurements 1. Serum total bilirubin and AL T levels were measured in the clinical laboratories of Presbyterian-University Hospital using standard methods. 2. Plasma insulin levels were determined by radioimmunoassay using an insulin kit obtained from Sera no Diagnostics (Boston, Mass.). The detection limit of the assay used was 5 .uU per ml. The intra-and interassay variations of the assay method for normal level samples were 6 and 10%, respectively. 3. Plasma glucagon levels were determined by radioimmunoassay using a glucagon kit obtained from Serono Diagnostics (Boston, Mass. Control assays consisting of incubation mixtures which had been immediately placed in boiling water were performed for all samples. Denatured protein was removed by centrifugation at 100 X g for 10 min and 100 ILl of the resultant supernatant were spotted on DEAE cellulose paper. The paper was then washed consecutively in 1 roM ammonium formate (5 min), distilled water (3 min) and the sequence was repeated again. The washed paper was placed in a scintillation vial to which 1 ml 0.1 M HCI and 0.2 M KCI was added. The vial was capped and shaken for 15 min. ACS (10 mll was then added and the radioactivity counted on a Tricarb 460 liquid scintillation counter. The detection limit for this assay is 15 fmoles per mg per min. The coefficient of variation for similar samples assayed as different days is <11 % (n = 10).
6. Protein determinations were performed using the method of Lowry (6) using bovine serum albumin as the standard. Histological Preparation and Examination of the Liver. At the time of sacrifice, specimens of liver tissue were obtained and fixed in 10% formalin and then embedded in paraffin. Sections 4 /Lm thick were cut and stained with hematoxylin-eosin. The sections were examined for evidence of regeneration as evidenced by the numbers of mitoses and multinucleated hepatocytes present within representative sections of Zones I and III.
Statistical Analysis. All results are reported as mean values ± S.E. All statistical analyses were performed using a twotailed Student's t test. A p value < 0.05 was considered to be significant.
RESULTS
In the first group of seven large dogs having a mean body weight of 23.7 ± 0.8 kg and a mean hepatic weight of 767 ± 48 gm, a liver obtained from 1 of 7 smaller dogs having a mean body weight of 13.2 ± 0.4 kg and a mean liver weight of 363 ± 20 gm was engrafted. The subsequent growth of the small-for-size liver in the larger recipient animals was followed for various lengths of time. Three dogs were allowed to live for a full 30 days following OLTx, at which time they were killed and the liver grafts were removed and reweighed. The four other large dogs transplanted either were sacrificed or died at earlier time points (10, 11, 13 and 31 days). In each case, however, the graft liver was removed and reweighed. Figure 1 (Parts 1 and 2) demonstrates the serial liver volumes determined by CT scanning in two of the 3-to 30-day surviving dogs which received a small-for-size organ graft. The four animals that survived for shorter periods showed similar changes in liver volume over time and were examined after intervals of 10, 11, 13 and 31 days as noted earlier .. Table 1 shows the growth of the transplanted small-for-size organs presented as per cent volume change over time for all seven of the animals studied.
In the second group of three animals having a mean having a mean body weight of 19.5 ± 4.5 kg and a liver weight of 523 ± 116 gm were used as the donor organs for OLTx. As can be seen from Figure 2 (Parts 1 to 3) , none of the transplanted organs in the same-sized recipients increased in size. In fact, in the recipient, they all decreased slightly in size and weight with time.
As can be seen in Figure 3 (A and B) , little or no changes in total bilirubin and a transient increase in AL T levels occurred in all of the animals studied. It should be noted that, although the bilirubin levels in the experimental group are uniformly greater than those in the control group for the first 12 days of the experiment, none of these differences are significant.
Similarly, plasma insulin and glucagon levels did not differ between the two groups, with insulin levels not changing over time and the glucagon level increasing 5-fold within 48 hr in both groups but then returning to normal levels by 96 hr after transplantation (Figure 4, A  and B) .
Hepatic levels of thymidine kinase increased in both groups of transplanted dogs reaching peak levels in 3 to 4 days. No difference was seen between the two groups of transplanted animals, however, either basally or at peak levels following transplantation ( Figure 5 ).
In contrast, although no difference was seen in the pretransplant basal levels of ornithine decarboxylase, the peak levels observed at 24 hr after transplantation were much greater in the experimental Group I animals than they were in the control Group II animals ( Figure 6) .
Histologically, the livers of the Group I animals all showed evidence of panlobular hepatic regeneration characterized by double and triple cell thick plates, numerous mitotic figures and moderate numbers of triplenucleated hepatocytes. In contrast, the livers of the Group II animals showed less evidence for regeneration which was limited to the area of Zone III (Table 2) .
DISCUSSION
The results of the present studies in dogs clearly demonstrate that the recipient's size determines the size of a transplanted liver in its new host. Moreover, they highlight the difference between the terms growth and regeneration. In animals that receive a small-for-size donor organ, the liver rapidly increases in size or grows until it achieves a size nearly identical to that of the recipient's own liver prior to hepatectomy (Figures 1 and  7) . In contrast, livers grafted into animals of the same size as the recipient actually atrophy slightly, although regeneration is evident in these livers (Figures 2 and 7) . These quite different changes in graft liver size or growth occur despite similar changes in serum total bilirubin and ALT levels and plasma levels of glucagon and insulin. Moreover, they occur despite similar changes in the hepatic content of thymidine kinase activity, the ratelimiting enzyme in DNA synthesis, over time. The only parameter that distinguished between the two groups of animals, those receiving small-for-size livers that increased in size and those that received normal-sized livers that atrophied, was the hepatic content of ornithine decarboxylase which increased in both groups of animals studied but more so in those given small-for-size donor organs. Thus, these data. suggest that thymidine kinase may be a marker for regeneration but that growth occurs only if ornithine decarboxylase is also increased above a certain level. Thus, ornithine decarboxylase which is known to be important in polyamine synthesis may be the putative initiator of growth. It is well-known that polyamines are involved in the regulation of rRNA synthesis and that blocking ornithine decarboxylase activity prevents regrowth of an injured organ presumably by preventing polyamine synthesis. (6) .
These data suggest further that the recipient's size determines, in large measure, the change in size that a liver graft will experience following successful transplantation. Taken together, these data suggest rather strongly that the liver growth experienced by a transplanted organ is either signaled by or initiated by a marked increase in the hepatic content of ornithine decarboxylase and presumably, although not tested in the present study, by the polyamine content of the liver. In contrast, changes in the plasma levels of insulin and glucagon or changes in the hepatic content of thymidine kinase appear not to be important in this regard although the activity of this latter enzyme certainly increases and is required for hepatic regeneration.
These data do not negate the considerable data available suggesting that both insulin and glucagon, as well as a host of insulin -like growth factors, are necessary for or capable of initiating hepatic regeneration under certain circumstances . In contrast, the present data extend such data and demonstrate that should the hepatic mass be appropriate for the metabolic demands of the host that despite such signals hepatic regeneration leading to hepatic growth does not occur. In contrast, when the hepatic mass is too small (inadequate) to meet the metabolic demands of the host, signals such as insulin, glucagon and other putative growth factors initiate a cascade of intracellular events culminating in a dramatic increase in ornithine decarboxylase activity which is followed not only by hepatic regeneration replacing dead or dying hepatocytes as seen in the controls, but also by actual hepatic growth as evidenced by a marked increase in the usual signs of hepatic regeneration but also and more importantly by an actual increase in the hepatic mass as evidenced by hepatic volume and weight measures.
The specific mechanisms responsible for the marked increase in the hepatic content of ornithine decarboxylase in enlarging liver grafts is not as yet known. Moreover, the sequence of events that either initiates or allows hepatic growth to occur in response to an increase in hepatic content of ornithine decarboxylase in a transplanted liver are also as yet poorly understood. Nonetheless, it appears that an increase in ornithine decarboxylase and, presumably, polyamines within the liver occurs and acts as the signal initiating hepatic growth such that the liver graft enlarges to a size that approximates the size of a normal liver expected to be present in the recipient.
